Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr
News

Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr

The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023

  • By IPP Bureau | August 03, 2023

Jagsonpal Pharmaceuticals Limited has reported Standalone financial results for the period ended June 30, 2023.

The company has posted net profit of Rs. 7.47 crores for the period ended June 30, 2023 as against net profit of Rs. 5.60 crores for the period ended March 31, 2023. It posted net profit of Rs.2.92 crores for the period ended June 30, 2022.

The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023 as compared to Rs. 58.01 crores during the period ended March 31, 2023. It reported total income of Rs.60.91 crores during the period ended June 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization